Jenny Jansen

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024.

Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024.

Journal: mBio

Published: September 12, 2025

Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.

Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 30, 2024

Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.

Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: January 12, 2024

Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens.

Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens.

Journal: Nature microbiology

Published: March 16, 2023

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.

Journal: Clinical and experimental medicine

Published: January 08, 2023

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.

Journal: PLoS pathogens

Published: October 31, 2022

Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.

Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.

Journal: Molecular systems biology

Published: February 07, 2022

Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies.

Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies.

Journal: Journal of clinical immunology

Published: November 21, 2021

SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.

SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.

Journal: PLoS biology

Published: November 11, 2021

A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913.

A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 12, 2021

Absence of cGAS-mediated type I IFN responses in HIV-1-infected T cells.

Absence of cGAS-mediated type I IFN responses in HIV-1-infected T cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 26, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026